サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1464683

神経幹細胞市場：タイプ別、用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Neural Stem Cells Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 278 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
神経幹細胞市場：タイプ別、用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月17日
発行: AnalystView Market Insights
ページ情報: 英文 278 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

神経幹細胞市場規模は2023年に67億5,600万米ドルとなり、2024年から2032年にかけてCAGR 12.5％で拡大

神経幹細胞市場- 市場力学

神経疾患に対する意識の高まりが市場需要を促進する見込み

神経疾患に対する認識が高まるにつれて、神経疾患の認識と診断が向上しています。その結果、早期診断が可能になり、治療への積極的なアプローチが行われるようになることが多いです。NSCsを含む再生療法は現在、治療の選択肢の一部として検討されています。国連の最近の報告書によると、アルツハイマー病、パーキンソン病、脳卒中、多発性硬化症、てんかん、片頭痛、脳損傷、神経感染症など、さまざまな神経疾患を患う人が6人に1人、合計10億人にのぼるといいます。悲しいことに、これらの疾患が原因で毎年約680万人が亡くなっています。CRISPR-Cas9などのバイオテクノロジーや遺伝子編集技術は、NSCsの治療可能性を高める有望な機会を提供しています。しかし、市場の成長は製造上の課題によって制限される可能性があります。

神経幹細胞市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約12.5%のCAGRで毎年成長すると予測されています。

市場別では、病院が2023年に最大の市場シェアを示すと予測されています。

地域別では、北米が2023年の売上高でトップでした。

神経幹細胞市場-セグメンテーション分析：

世界の神経幹細胞市場は、タイプ、用途、地域に基づいてセグメント化されます。

市場はタイプによって3つのグループに分類される：神経管上皮細胞、神経膠細胞、神経芽細胞、神経前駆細胞です。神経幹細胞市場は、神経科学研究、再生医療、治療開発において用途を見出す、明確な特性を有する幅広いタイプの細胞から構成されます。

市場は用途によって3つのカテゴリーに区分される：医療、病院、研究室です。同市場では、幹細胞臨床試験に関与する患者を含む神経疾患や傷害を持つ患者に対して、広範なケアやリハビリテーションサービスを提供する病院カテゴリーが圧倒的なシェアを占めています。

神経幹細胞市場-地理的洞察

神経幹細胞市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカに地理的に広がっています。これらの地域は、事業活動を行っている国に基づいてさらに区分されます。北米地域が市場を独占しているのは、主にその先進的なヘルスケア・インフラによるものです。この地域の強力なヘルスケア・インフラは、幹細胞生物学と再生医療の分野における広範な研究開発を支えています。2022年末までに、米国はヘルスケアに4兆5,000億米ドルを費やすと予測されており、世界で最もヘルスケア支出が多い国となっています。2021年、米国のヘルスケア支出は4兆3,000億米ドルと推定され、GDPの18.5％を占める。欧州は市場成長において2番目に大きな地域を占めているが、これは主に研究開発への取り組みが活発であることに起因しています。

神経幹細胞市場-競合情勢：

神経幹細胞市場は、再生医療への注目の高まりと、さまざまな神経疾患の治療における幹細胞治療の有望な可能性から、非常に競争の激しい市場となっています。数多くの企業や研究機関が、神経幹細胞を用いた製品や治療法の開発・商業化に積極的に取り組んでいます。これらの企業は、製品のイノベーション、研究開発、戦略的パートナーシップ、市場拡大の取り組みを通じて、神経幹細胞市場における競合優位性を獲得しようと努力しています。

目次

第1章 神経幹細胞市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 神経幹細胞の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 神経幹細胞産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 神経幹細胞市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 神経幹細胞市場情勢

  • 神経幹細胞市場シェア分析、2022年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 神経幹細胞市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 神経管上皮細胞
    • 神経膠細胞
    • 神経芽細胞
    • 神経前駆細胞

第8章 神経幹細胞市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 医療
    • 病院
    • 研究室

第9章 神経幹細胞市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 神経幹細胞業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Cellular Dynamics International
    • Stemedica Cell Technologies Inc
    • Fibrocell Science Inc
    • Corestem Inc, Corning Inc.
    • Celgene Corporation
    • Kangstem Biotech Ltd
    • Ge Healthcare
    • Biotime Inc
    • Thermo Fisher Vericel Corporation
    • Cellular Engineering Technologies Inc
    • Brainstorm Cell Therapeutics
    • Cytori Therapeutics
    • Becton Dickinson
    • Takara Holdings Inc.
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Neural Stem Cells Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Neural Stem Cells Market, by Product Type 2018-2030 (USD Million)
  • TABLE Neural Stem Cells Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Neural Stem Cells Market, by Application 2018-2030 (USD Million)
  • TABLE Neural Stem Cells Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Neural Stem Cells Market, by Region 2018-2030 (USD Million)
  • TABLE North America Neural Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Neural Stem Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Neural Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Neural Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Neural Stem Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Neural Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neural Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neural Stem Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neural Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Neural Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Neural Stem Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Neural Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neural Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neural Stem Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neural Stem Cells Market, by Application, 2018-2030 (USD Million)
目次
Product Code: ANV2489

REPORT HIGHLIGHT

Neural Stem Cells Market size was valued at USD 6,756 Million in 2023, expanding at a CAGR of 12.5% from 2024 to 2032.

Neural stem cells are undifferentiated cells found in the central nervous system. These cells can produce new cells that can mature into neurons and glial cells. Ongoing research on neural stem cells aims to explore their potential in regenerative medicine and neuroscience, with a focus on understanding their characteristics, controlling their functions, and creating reliable treatments for neurological conditions.

Neural Stem Cells Market- Market Dynamics

Increasing awareness about neurological disease is expected to propel market demand

The recognition and diagnosis of neurological diseases have improved as awareness about these conditions increases. This has led to early diagnosis, which often results in a proactive approach to treatment. Regenerative therapies involving NSCs are now being considered as part of the treatment options. According to a recent United Nations report, approximately one in six people, totaling up to 1 billion individuals, suffer from various neurological disorders, including Alzheimer's disease, Parkinson's disease, strokes, multiple sclerosis, epilepsy, migraines, brain injuries, and neuro-infections. Sadly, around 6.8 million people die each year due to these conditions. Biotechnology and gene editing techniques, such as CRISPR-Cas9, present promising opportunities for enhancing the therapeutic potential of NSCs. However, the growth of the market may be limited by manufacturing challenges.

Neural Stem Cells Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.5% over the forecast period (2024-2032)

Based on Application segmentation, Hospital was predicted to show maximum market share in the year 2023

Based on region, North America was the leading revenue generator in 2023

Neural Stem Cells Market- Segmentation Analysis:

The Global Neural Stem Cells Market is segmented based on Type, Application, and Region.

The market is categorized into three groups according to Type: Neural tube epithelial cells, Neuroglial cells, Neuroblast, and Neural precursor cells. The Neural Stem Cells market comprises a wide range of cell types that possess distinct properties and find applications in neuroscience research, regenerative medicine, and therapeutic development.

The market is segmented into three categories according to their application: Medical care, Hospital, and Laboratory. The dominant sector in the market is the Hospital category, which offers extensive care and rehabilitation services to patients with neurological disorders and injuries, including those involved in stem cell clinical trials.

Neural Stem Cells Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The North American region dominates the market, primarily due to its advanced healthcare infrastructure. The strong healthcare infrastructure in this region supports extensive research and development in the field of stem cell biology and regenerative medicine. By the end of 2022, the United States is projected to spend USD 4.5 trillion on healthcare, making it the country with the highest overall healthcare spending in the world. In 2021, the United States' healthcare spending is estimated to be USD 4.3 trillion, accounting for 18.5% of its GDP. Europe holds the second-largest region for market growth, mainly attributed to its robust research and development efforts.

Neural Stem Cells Market- Competitive Landscape:

The market for neural stem cells is highly competitive due to the increasing focus on regenerative medicine and the promising potential of stem cell therapies in treating different neurological disorders. Numerous companies and research institutions are actively engaged in the advancement and commercialization of products and therapies based on neural stem cells. These companies are striving to gain a competitive advantage in the neural stem cells market through product innovation, research and development, strategic partnerships, and market expansion efforts.

Recent Developments:

In January 2023, Stemedica Cell Technologies has revealed the initiation of a phase 2b/3 clinical trial aimed at evaluating the safety, effectiveness, and tolerance of a sole IV injection of allogeneic mesenchymal stem cells in individuals suffering from chronic ischemic stroke.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEURAL STEM CELLS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Cellular Dynamics International

Stemedica Cell Technologies Inc

Fibrocell Science Inc

Corestem Inc, Corning Inc.

Celgene Corporation

Kangstem Biotech Ltd

Ge Healthcare

Biotime Inc

Thermo Fisher Vericel Corporation

Cellular Engineering Technologies Inc

Brainstorm Cell Therapeutics

Cytori Therapeutics

Becton Dickinson

Takara Holdings Inc.

Others

GLOBAL NEURAL STEM CELLS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Neural tube epithelial cells
  • Neuroglial cell
  • Neuroblast
  • Neural precursor cell

GLOBAL NEURAL STEM CELLS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Medical care
  • Hospital
  • Laboratory

GLOBAL NEURAL STEM CELLS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Neural Stem Cells Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Neural Stem Cells Market Snippet by Product Type
    • 2.1.2.Neural Stem Cells Market Snippet by Application
    • 2.1.3.Neural Stem Cells Market Snippet by Country
    • 2.1.4.Neural Stem Cells Market Snippet by Region
  • 2.2.Competitive Insights

3.Neural Stem Cells Key Market Trends

  • 3.1.Neural Stem Cells Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Neural Stem Cells Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Neural Stem Cells Market Opportunities
  • 3.4.Neural Stem Cells Market Future Trends

4.Neural Stem Cells Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Neural Stem Cells Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Neural Stem Cells Market Landscape

  • 6.1.Neural Stem Cells Market Share Analysis, 2022
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Neural Stem Cells Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2.Neural tube epithelial cells
    • 7.1.3.Neuroglial cell
    • 7.1.4.Neuroblast
    • 7.1.5.Neural precursor cell

8.Neural Stem Cells Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2.Medical care
    • 8.1.3.Hospital
    • 8.1.4.Laboratory

9.Neural Stem Cells Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Neural Stem Cells Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Neural Stem Cells Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Neural Stem Cells Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Neural Stem Cells Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Neural Stem Cells Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10.Key Vendor Analysis- Neural Stem Cells Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Cellular Dynamics International
    • 10.2.2.Stemedica Cell Technologies Inc
    • 10.2.3.Fibrocell Science Inc
    • 10.2.4.Corestem Inc, Corning Inc.
    • 10.2.5.Celgene Corporation
    • 10.2.6.Kangstem Biotech Ltd
    • 10.2.7.Ge Healthcare
    • 10.2.8.Biotime Inc
    • 10.2.9.Thermo Fisher Vericel Corporation
    • 10.2.10.Cellular Engineering Technologies Inc
    • 10.2.11.Brainstorm Cell Therapeutics
    • 10.2.12.Cytori Therapeutics
    • 10.2.13.Becton Dickinson
    • 10.2.14.Takara Holdings Inc.
    • 10.2.15.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us